Self-reported Morisky score for identifying nonadherence with cardiovascular medications

The Annals of Pharmacotherapy
Stephen J ShalanskyAndrew P Ignaszewski

Abstract

The Morisky medication adherence scale is a commonly used adherence screening tool. It is composed of 4 yes/no questions about past medication use patterns and is thus quick and simple to use during drug history interviews. To evaluate the use of the self-reported Morisky score as a screening tool for identifying patients who have been nonadherent with chronic cardiovascular medications. Patients who had taken an angiotensin-converting enzyme inhibitor or lipid-lowering agent for at least 3 consecutive months were interviewed using a structured questionnaire including the Morisky scale. Nonadherence was defined as taking < 80% of chronic cardiovascular medications based on prescription refill data over the previous 14 months. Forty-nine of 377 (13%) patients were categorized as nonadherent; however, only 12 (3%) patients had Morisky scores suggesting a high likelihood of nonadherence (3 or 4). While the Morisky score was a significant independent predictor of nonadherence by multivariate analysis, there was no threshold score or individual question that yielded concurrent high sensitivity and positive predictive values (PPVs) for identifying nonadherent patients. The internal consistency of the questions was low (alpha 0.32), a...Continue Reading

References

Jan 1, 1994·The Annals of Pharmacotherapy·G SchectmanA Hartz
Dec 1, 1996·Journal of Clinical Epidemiology·P PeduzziA R Feinstein
Apr 14, 1999·The Annals of Pharmacotherapy·F VenturiniJ S McCombs
Aug 10, 2000·British Journal of Clinical Pharmacology·C F GeorgeC Thompson
Oct 31, 2000·The Annals of Pharmacotherapy·X Gao, D P Nau
Sep 28, 2001·The Annals of Pharmacotherapy·S R EricksonA R Azimi
Oct 30, 2001·American Journal of Epidemiology·S SchneeweissR J Glynn
Jul 23, 2002·JAMA : the Journal of the American Medical Association·Joshua S BennerJerry Avorn
Sep 24, 2002·The Annals of Pharmacotherapy·Stephen J Shalansky, Adrian R Levy

❮ Previous
Next ❯

Citations

Nov 26, 2013·Research in Social & Administrative Pharmacy : RSAP·Alfredo Dias de Oliveira-FilhoDivaldo Pereira de Lyra
Apr 9, 2014·International Journal of Clinical Pharmacy·Sheila A Doggrell, Servane Warot
May 17, 2014·SpringerPlus·Solomon Mekonnen AbebeAlemayehu Worku
Oct 23, 2013·Internal and Emergency Medicine·Marco AmbrosettiCesare Greco
Jun 14, 2013·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Bernard Waeber, François Feihl
Apr 25, 2007·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Benjamin A TollStephanie S O'Malley
Sep 29, 2009·Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association·Tamara L HayesSengul Vurgun
Nov 5, 2011·BMC Medical Research Methodology·Sara GarfieldAlan Willson
Feb 22, 2012·Clinical Journal of the American Society of Nephrology : CJASN·Tara I ChangWolfgang C Winkelmayer
Jun 28, 2011·European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology·Yeon-Hwan ParkChin Kang Koh
Nov 10, 2011·Journal of Immigrant and Minority Health·Jennifer A ColbyRafael Pérez-Escamilla
Jun 22, 2011·International Journal of Clinical Pharmacy·Péter DoróGyöngyvér Soós
Mar 3, 2010·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Christopher N JarmanCarrie Farmer Teh
Aug 7, 2008·Pharmacogenomics·Catherine Buettner, Stewart H Lecker
Sep 10, 2013·European Journal of Clinical Pharmacology·Carlos De las CuevasEmilio J Sanz
Aug 1, 2007·Cardiovascular Drugs and Therapy·Devin M MannMary Charlson
Mar 18, 2016·Journal of Research in Pharmacy Practice·Fataneh Hashem DabaghianRoshanak Ghods
Feb 14, 2016·Aging Clinical and Experimental Research·Stefano GonnelliRanuccio Nuti
May 5, 2005·Journal of the American Pharmacists Association : JAPhA·Bonnie L Svarstad
Jan 21, 2011·Journal of the American Pharmacists Association : JAPhA·Stacey M LavsaNicole T Ansani
Aug 6, 2010·Patient Education and Counseling·Sunil KripalaniTerry A Jacobson
May 18, 2010·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Paul MuntnerMonika M Safford
Feb 11, 2010·Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria·J Hernández MartínJ L Poveda Andrés
Apr 16, 2009·Journal of Evaluation in Clinical Practice·Nina van de SteegAttila Altiner
Apr 18, 2008·Néphrologie & thérapeutique·Sidy Mohamed SeckBoucar Diouf
Nov 2, 2006·British Journal of Clinical Pharmacology·Johnson George, Stephen J Shalansky
Jan 5, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·F ValldeoriolaUNKNOWN ADHESON Study Group
Jun 8, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·Y WangY Ko
Jul 19, 2011·The Journal of Clinical Hypertension·Paul MuntnerMarie Krousel-Wood
Apr 19, 2011·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Charitini Stavropoulou
Jun 5, 2013·The Journal of Clinical Hypertension·Barry L CarterUNKNOWN Collaboration Among Pharmacists and Physicians to Improve Outcomes Now (CAPTION) trial investigators
Oct 4, 2012·The Journal of Clinical Hypertension·Marguerite R IrvinPaul Muntner
Dec 10, 2013·Journal of Advanced Nursing·Laura Bacelar de Araujo LourençoMaria-Cecília Gallani

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.